Lusay, Marcito G.
HRN: 23-01-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/17/2023
IVT
2gms
Od
T/c Abdominal Mass, R/o Malignancy; T/c Pulmonary Mass Probably In Metastatic Origin
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes